Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. - Wikidata - awgldk - TriplyDB

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

http://www.wikidata.org/entity/Q34080984

about

Current Treatment Approaches to HCC with a Special Consideration to Transplantation The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future Hepatocellular Carcinoma and Liver Transplantation: State of the Art Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system Role of liver transplantation for hepatocellular carcinoma Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation Recent advances in multidisciplinary management of hepatocellular carcinoma Treatment of hepatocellular carcinoma: Steps forward but still a long way to go Liver transplantation for hepatocellular carcinoma Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation Liver transplantation for hepatic tumors: a systematic review Hepatocellular carcinoma: a review Liver transplantation for advanced hepatocellular carcinoma Hepatocellular carcinoma: A comprehensive review 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.Does external beam radiation therapy improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma?Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Current management of hepatocellular carcinoma.Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?Value of radiofrequency ablation in the treatment of hepatocellular carcinoma Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.Recent advances in liver transplantation for the practicing gastroenterologist A multidisciplinary approach to the management of hepatocellular carcinoma.Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC.Updates in the management of hepatocellular carcinoma

P2860

Q26740375-71D1C8E4-0BB7-4C8B-9DDB-EF45D9101631 Q26741882-D49D2AC6-03B9-405D-84C9-E2A8382133B3 Q26770014-13193A61-D49F-42BF-906D-9092B4E61897 Q26771246-8571FA7F-1C31-45BC-B36E-772E692094BA Q26781798-CB178711-DF49-47A8-AD95-1F49CE3E05C9 Q26784223-5F48230C-4848-42DE-ACC5-AB7326D56B8C Q26822581-57E28F13-6F70-4525-B1FC-62B971554FED Q26851272-56D149DA-A29F-486D-A794-5BC527A5A8B7 Q26852105-99800EC2-7499-4974-8692-EC4D189213A2 Q26863748-A305242F-0105-4E69-9070-1C74A6074506 Q26865456-09742923-9200-440A-9CF7-93E9B1AE3B96 Q26997618-3AC92FC7-4A90-460B-98CB-EB09AD45B6AB Q27014758-A09FD5E6-C680-4A5D-BDBF-3FD3A75F5AB0 Q27021650-33E0F284-F291-4B6E-9D73-045C43FC69C9 Q28069290-801A2989-5F54-444A-82D4-EB95FB58FB44 Q28074653-46DD76CC-C0E1-4E5E-9D57-74E5359E9D93 Q28087638-EE766AB8-0782-4D16-A80C-74D6AEBF928B Q28392783-CBBB39F8-80E8-4CFC-90DA-2B4320A273E7 Q28394414-DBC11763-1D77-4943-8D5E-CDAA921C6893 Q30276330-6AB73ABD-7BAA-4ABA-9C8D-4F14AA60FA23 Q30416480-B8CD8032-49BE-4309-B5BF-5207E99C4E1F Q30426959-4C0343EF-50CF-470A-95A1-A655DE7E280A Q30432108-84926E3E-F3E8-4036-A657-722C2F96E271 Q30468280-05AF5BA1-84E8-4F04-8D64-C5EA72062170 Q30479629-93C3B547-5622-4799-91C2-908EA379E59C Q33582165-FCEA0A75-8245-44BD-83C0-A248F4E61AAA Q33594862-1F5CC722-E9CF-47DD-937C-742C62CA321C Q33661046-A47D6E2B-AD2B-4A27-89F8-9037C07139D1 Q33738482-F5D1FB3A-DF25-48CE-B6D3-AD7F4483CADD Q33869846-A9369737-B1A7-4C20-8713-00E12505EC65 Q33913779-34715836-CFCA-4739-B9CD-DEB8F6CF568B Q33916188-26ADBC09-D5FE-40C5-929C-15D97F02E81F Q33916361-26E6C506-DDA7-48B8-9B92-FCDF1BAB297E Q34135201-9D2C6A30-D3C1-4071-AAAC-C9A266698F70 Q34165248-F8C6DF7D-E331-4B77-AFFC-704B572B8359 Q34201437-EC93D86F-F9DE-4DE8-98D9-6793069D358E Q34409128-ED8B715A-67E3-43FE-8E1C-67A2EEE70995 Q34504657-4DAA4CEE-B66B-4AE8-AF47-C29F70A07958 Q34562491-85B82168-9E72-41AE-98F6-71FFD072C614 Q34571160-9B8C753F-953E-48A0-8B92-7DB78E8E3711

P2860

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

http://www.wikidata.org/entity/Q34080984

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Excellent outcome following do ...... n intention-to-treat analysis.

@ast

Excellent outcome following do ...... n intention-to-treat analysis.

@en

Excellent outcome following do ...... n intention-to-treat analysis.

@nl

type

label

Excellent outcome following do ...... n intention-to-treat analysis.

@ast

Excellent outcome following do ...... n intention-to-treat analysis.

@en

Excellent outcome following do ...... n intention-to-treat analysis.

@nl

prefLabel

Excellent outcome following do ...... n intention-to-treat analysis.

@ast

Excellent outcome following do ...... n intention-to-treat analysis.

@en

Excellent outcome following do ...... n intention-to-treat analysis.

@nl

P1433

Q34080984-660B13DB-9B84-44A3-AF28-968B3661CF7A

P1476

Q34080984-28DD1617-BBD1-4720-AEA8-EBAD6A779553

P2093

Q34080984-13E5AB85-03E5-49D4-BFAE-D8EE285CA474

Q34080984-16E57ADE-38E4-4EB7-A92E-FA0E00947C5B

Q34080984-2166872B-64FD-4AFF-8526-8216CD7D1F49

Q34080984-24AF9A42-BC39-40B8-B565-EEDBB82642EF

Q34080984-30A85AD4-BA3D-4879-9289-1008CF69D8DB

Q34080984-45F0C026-496C-49FF-91A8-B111480BFA83

Q34080984-64381E74-31C2-40EC-9347-9433317CA158

Q34080984-66F2DC79-2E52-486E-A094-3094DA84F1A8

Q34080984-8425E863-0AF3-4BD4-864F-B654C1AF155C

Q34080984-9B6FF2A5-EB0B-4D1A-B83A-ED26C31CF9D1

P2860

Q34080984-16BDA86A-A778-4FC2-BA79-7E3474EFF852

Q34080984-295EFDA8-A749-47BE-918F-B28AA12A3D4F

Q34080984-2BF04807-83A6-4A27-83F9-0B19A1EE64FD

Q34080984-46649197-5EFA-46EC-83AC-3F46C6256E1F

Q34080984-46FE317B-2331-4B05-8ABE-B4C9595A4E30

Q34080984-5C7A046C-9730-462A-A258-52ED851BAB0E

Q34080984-5E05AF5A-A61D-43DC-8936-7AB2E08A13CC

Q34080984-5FFD9130-26AD-4CCD-B882-E53B172D796B

Q34080984-71E518E0-1DDF-482E-BC03-5CC753DF6C98

Q34080984-720FBDE0-A9FB-4274-B69A-876270B3D2C4

P304

Q34080984-866EA1F6-B9EA-4AD3-8019-1A5D2470F631

P31

Q34080984-143A7AF9-B279-419F-A5F0-FCF192C6C23D

P356

Q34080984-9A1A568E-8C79-4452-B4B8-935540FA9BBE

P407

Q34080984-56B2A8D6-5371-463F-8CC9-833B97FF6E25

P433

Q34080984-493BF682-9E6B-453D-9FE3-D1CD5A749F7F

P478

Q34080984-966041FA-EE8E-46E9-91DA-48A116284AC3

P577

Q34080984-E9501BB7-592F-498C-9DAE-079178840CF9

P5875

Q34080984-CF99FAF1-8612-4A84-AC84-0866E321EF23

P698

Q34080984-F2EEC622-EE95-4E22-A620-7F68D4BC28C2

P921

Q34080984-C9ABAC05-8C16-4FD8-8665-5B0AAC3E50B4

P932

Q34080984-8E766E70-CEB6-4A07-BBF7-C180D4FF214F

P356

P1433

P1476

Excellent outcome following do ...... n intention-to-treat analysis.

@en

P2093

Chris E Freise

http://www.w3.org/2001/XMLSchema#string

Francis Y Yao

http://www.w3.org/2001/XMLSchema#string

John P Roberts

http://www.w3.org/2001/XMLSchema#string

Marion Peters

http://www.w3.org/2001/XMLSchema#string

Nancy L Ascher

http://www.w3.org/2001/XMLSchema#string

Nathan M Bass

http://www.w3.org/2001/XMLSchema#string

Norah Terrault

http://www.w3.org/2001/XMLSchema#string

Robert K Kerlan

http://www.w3.org/2001/XMLSchema#string

Ryutaro Hirose

http://www.w3.org/2001/XMLSchema#string

Sandy Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Transection of the oesophagus for bleeding oesophageal varices.

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.

Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy.

Living donor liver transplantation for hepatocellular carcinoma.

Hepatic transplantation for primary and metastatic cancers of the liver.

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Indications for liver transplantation in hepatobiliary malignancy.

P304

819-827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22412

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23157632

http://www.w3.org/2001/XMLSchema#string

P698

18688876

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

4142499

http://www.w3.org/2001/XMLSchema#string